202 related articles for article (PubMed ID: 11726559)
1. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
Seznec H; Agbulut O; Sergeant N; Savouret C; Ghestem A; Tabti N; Willer JC; Ourth L; Duros C; Brisson E; Fouquet C; Butler-Browne G; Delacourte A; Junien C; Gourdon G
Hum Mol Genet; 2001 Nov; 10(23):2717-26. PubMed ID: 11726559
[TBL] [Abstract][Full Text] [Related]
2. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
[TBL] [Abstract][Full Text] [Related]
3. Myotonic dystrophy: RNA pathogenesis comes into focus.
Ranum LP; Day JW
Am J Hum Genet; 2004 May; 74(5):793-804. PubMed ID: 15065017
[TBL] [Abstract][Full Text] [Related]
4. Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.
Kuyumcu-Martinez NM; Cooper TA
Prog Mol Subcell Biol; 2006; 44():133-59. PubMed ID: 17076268
[TBL] [Abstract][Full Text] [Related]
5. Choroid plexus mis-splicing and altered cerebrospinal fluid composition in myotonic dystrophy type 1.
Nutter CA; Kidd BM; Carter HA; Hamel JI; Mackie PM; Kumbkarni N; Davenport ML; Tuyn DM; Gopinath A; Creigh PD; Sznajder ŁJ; Wang ET; Ranum LPW; Khoshbouei H; Day JW; Sampson JB; Prokop S; Swanson MS
Brain; 2023 Oct; 146(10):4217-4232. PubMed ID: 37143315
[TBL] [Abstract][Full Text] [Related]
6. Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1.
Wheeler TM; Krym MC; Thornton CA
Neuromuscul Disord; 2007 Mar; 17(3):242-7. PubMed ID: 17306536
[TBL] [Abstract][Full Text] [Related]
7. Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.
Kanadia RN; Shin J; Yuan Y; Beattie SG; Wheeler TM; Thornton CA; Swanson MS
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11748-53. PubMed ID: 16864772
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics and genetic testing in myotonic dystrophy type 1.
Savić Pavićević D; Miladinović J; Brkušanin M; Šviković S; Djurica S; Brajušković G; Romac S
Biomed Res Int; 2013; 2013():391821. PubMed ID: 23586035
[TBL] [Abstract][Full Text] [Related]
9. Myotonic dystrophy: approach to therapy.
Thornton CA; Wang E; Carrell EM
Curr Opin Genet Dev; 2017 Jun; 44():135-140. PubMed ID: 28376341
[TBL] [Abstract][Full Text] [Related]
10. Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial.
Kurkiewicz A; Cooper A; McIlwaine E; Cumming SA; Adam B; Krahe R; Puymirat J; Schoser B; Timchenko L; Ashizawa T; Thornton CA; Rogers S; McClure JD; Monckton DG
PLoS One; 2020; 15(4):e0231000. PubMed ID: 32287265
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.
Miller JW; Urbinati CR; Teng-Umnuay P; Stenberg MG; Byrne BJ; Thornton CA; Swanson MS
EMBO J; 2000 Sep; 19(17):4439-48. PubMed ID: 10970838
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Myokine Signaling in Congenital Myotonic Dystrophy.
Nakamori M; Hamanaka K; Thomas JD; Wang ET; Hayashi YK; Takahashi MP; Swanson MS; Nishino I; Mochizuki H
Cell Rep; 2017 Oct; 21(5):1240-1252. PubMed ID: 29091763
[TBL] [Abstract][Full Text] [Related]
13. Cells of Matter-
Matloka M; Klein AF; Rau F; Furling D
Front Neurol; 2018; 9():361. PubMed ID: 29875732
[TBL] [Abstract][Full Text] [Related]
14. Myotonic dystrophy type 1 testing, 2024 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG).
Seifert BA; Reddi HV; Kang BE; Bean LJH; Shealy A; Rose NC;
Genet Med; 2024 Jun; ():101145. PubMed ID: 38836869
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Single Nucleotide Polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients.
Rinaldi F; Botta A; Vallo L; Contino G; Morgante A; Iraci R; Catalli C; Silvestri G; Ventriglia VM; Politano L; Novelli G
Acta Myol; 2008 Dec; 27(3):82-9. PubMed ID: 19472917
[TBL] [Abstract][Full Text] [Related]
16. NMR spectroscopy and molecular dynamics simulation of r(CCGCUGCGG)₂ reveal a dynamic UU internal loop found in myotonic dystrophy type 1.
Parkesh R; Fountain M; Disney MD
Biochemistry; 2011 Feb; 50(5):599-601. PubMed ID: 21204525
[TBL] [Abstract][Full Text] [Related]
17. Myotonic dystrophy: therapeutic strategies for the future.
Wheeler TM
Neurotherapeutics; 2008 Oct; 5(4):592-600. PubMed ID: 19019311
[TBL] [Abstract][Full Text] [Related]
18. Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1.
Mahdavi M; Prévost K; Balthazar P; Hus IF; Duchesne É; Dumont N; Gagné-Ouellet V; Gagnon C; Laforest-Lapointe I; Massé E
Comput Struct Biotechnol J; 2024 Dec; 23():2097-2108. PubMed ID: 38803516
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review.
Wu Y; Wei Q; Lin J; Shang H; Ou R
Front Cell Neurosci; 2024; 18():1369332. PubMed ID: 38638300
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
